We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLGT icon
2501
Fulgent Genetics
FLGT
$527M
$1.46M ﹤0.01%
74,572
-171,478
-70% -$3.58M
BATRA icon
2502
Atlanta Braves Holdings Series A
BATRA
$3.43B
$1.46M ﹤0.01%
35,279
+8,235
+30% +$341K
MSBI icon
2503
Midland States Bancorp
MSBI
$695M
$1.46M ﹤0.01%
64,373
+5,500
+9% +$127K
RUSHB icon
2504
Rush Enterprises Class B
RUSHB
$6.14B
$1.46M ﹤0.01%
37,124
-1,472
-4% -$63.6K
ALNT icon
2505
Allient
ALNT
$1.92B
$1.46M ﹤0.01%
57,585
+25,707
+81% +$737K
EYPT icon
2506
EyePoint Inc
EYPT
$1.2B
$1.45M ﹤0.01%
167,196
+10,623
+7% +$148K
INDV icon
2507
Indivior Pharmaceuticals
INDV
$4.58B
$1.45M ﹤0.01%
92,759
PHAT icon
2508
Phathom Pharmaceuticals
PHAT
$692M
$1.45M ﹤0.01%
141,022
-121,026
-46% -$1.25M
CHGG icon
2509
Chegg
CHGG
$102M
$1.45M ﹤0.01%
459,258
-15,960
-3% -$79.3K
BHRB icon
2510
Burke & Herbert Financial Services Corp
BHRB
$1.48B
$1.45M ﹤0.01%
28,464
+15,942
+127% +$813K
FFIC
2511
DELISTED
Flushing Financial
FFIC
$1.45M ﹤0.01%
110,311
+21,310
+24% +$260K
ACEL icon
2512
Accel Entertainment
ACEL
$987M
$1.45M ﹤0.01%
141,179
-367,285
-72% -$3.89M
SVRA icon
2513
Savara
SVRA
$1.19B
$1.45M ﹤0.01%
359,251
+197,039
+121% +$877K
OSBC icon
2514
Old Second Bancorp
OSBC
$1.29B
$1.45M ﹤0.01%
97,703
+6,720
+7% +$94.5K
APLD icon
2515
Applied Digital
APLD
$8.41B
$1.44M ﹤0.01%
242,132
+33,071
+16% +$128K
PKX icon
2516
POSCO
PKX
$17.5B
$1.44M ﹤0.01%
21,911
-24
-0.1% -$1.7K
RILY icon
2517
BRC Group Holdings
RILY
$289M
$1.44M ﹤0.01%
81,561
-15,355
-16% -$395K
VTWO icon
2518
Vanguard Russell 2000 ETF
VTWO
$17.9B
$1.44M ﹤0.01%
17,540
-61,490
-78% -$5.03M
LSEA
2519
DELISTED
Landsea Homes
LSEA
$1.43M ﹤0.01%
156,009
+26,280
+20% +$279K
REPX icon
2520
Riley Exploration Permian
REPX
$758M
$1.43M ﹤0.01%
50,631
+21,698
+75% +$598K
LFST icon
2521
Lifestance Health
LFST
$4.14B
$1.43M ﹤0.01%
291,739
+17,313
+6% +$104K
XPER icon
2522
Xperi
XPER
$348M
$1.42M ﹤0.01%
173,384
-29,234
-14% -$276K
SEI
2523
Solaris Energy Infrastructure
SEI
$3.82B
$1.42M ﹤0.01%
165,361
+59,450
+56% +$520K
DX
2524
Dynex Capital
DX
$3.21B
$1.41M ﹤0.01%
117,969
+9,648
+9% +$116K
ANAB icon
2525
AnaptysBio
ANAB
$1.68B
$1.4M ﹤0.01%
56,012
-8,228
-13% -$192K

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.